Hansen LL

References (3)

Title : Tacrine is not an ideal probe drug for measuring CYP1A2 activity in vivo - Larsen_1999_Br.J.Clin.Pharmacol_48_663
Author(s) : Larsen JT , Hansen LL , Brosen K
Ref : British Journal of Clinical Pharmacology , 48 :663 , 1999
Abstract : Larsen_1999_Br.J.Clin.Pharmacol_48_663
ESTHER : Larsen_1999_Br.J.Clin.Pharmacol_48_663
PubMedSearch : Larsen_1999_Br.J.Clin.Pharmacol_48_663
PubMedID: 10594467

Title : Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo - Larsen_1999_Eur.J.Clin.Pharmacol_55_375
Author(s) : Larsen JT , Hansen LL , Spigset O , Brosen K
Ref : European Journal of Clinical Pharmacology , 55 :375 , 1999
Abstract : Larsen_1999_Eur.J.Clin.Pharmacol_55_375
ESTHER : Larsen_1999_Eur.J.Clin.Pharmacol_55_375
PubMedSearch : Larsen_1999_Eur.J.Clin.Pharmacol_55_375
PubMedID: 10456487

Title : Determination of tacrine and its metabolites in human plasma and urine by high-performance liquid chromatography and fluorescence detection - Hansen_1998_J.Chromatogr.B.Biomed.Sci.Appl_712_183
Author(s) : Hansen LL , Larsen JT , Brosen K
Ref : Journal of Chromatography B Biomed Sci Appl , 712 :183 , 1998
Abstract : Hansen_1998_J.Chromatogr.B.Biomed.Sci.Appl_712_183
ESTHER : Hansen_1998_J.Chromatogr.B.Biomed.Sci.Appl_712_183
PubMedSearch : Hansen_1998_J.Chromatogr.B.Biomed.Sci.Appl_712_183
PubMedID: 9698241